KCNAB2 overexpression inhibits human non-small-cell lung cancer cell growth in vitro and in vivo

Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancer cases. NSCLC patients often have poor prognosis demanding urgent identification of novel biomarkers and potential therapeutic targets. KCNAB2 (regulatory beta subunit2 of voltage-gated potassium channel), encoding a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Feng, Tang, Yu-fei, Cao, Yang, Peng, Shi-qing, Zhu, Xiao-ren, Sun, Yue, Wang, Shu-Hang, Wang, Bin, Lu, Yi-min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584983/
https://www.ncbi.nlm.nih.gov/pubmed/37852974
http://dx.doi.org/10.1038/s41420-023-01679-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584983/
https://www.ncbi.nlm.nih.gov/pubmed/37852974
http://dx.doi.org/10.1038/s41420-023-01679-5

Ejemplares similares